Patient-reported Outcomes in High-Risk HR+ /HER2- Early Breast Cancer Patients Treated with Endocrine Therapy with or Without Palbociclib Within the Randomized PENELOPEB Study.
European Journal of Cancer（2024）
关键词
Breast cancer,High -risk HR + /HER2 early breast cancer,Palbociclib,Post-neoadjuvant,QoL
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要